HIV pre-exposure prophylaxis implementation cascade among health care professionals in the United States: implications from a systematic review and meta-analysis
Although pre-exposure prophylaxis (PrEP) has been approved for primary HIV prevention
for individuals aged 18 years or older since 2012, PrEP utilization has been suboptimal. To …
for individuals aged 18 years or older since 2012, PrEP utilization has been suboptimal. To …
Evolving models and ongoing challenges for HIV preexposure prophylaxis implementation in the United States
Background: The use of preexposure prophylaxis (PrEP) for HIV prevention was approved
by the Food and Drug Administration in 2012, but delivery to at-risk persons has lagged …
by the Food and Drug Administration in 2012, but delivery to at-risk persons has lagged …
Why I quit pre-exposure prophylaxis (PrEP)? A mixed-method study exploring reasons for PrEP discontinuation and potential re-initiation among gay and bisexual …
Literature concerning pre-exposure prophylaxis (PrEP) among gay and bisexual identifying
men (GBM) has explored facilitators and barriers to uptake and adherence. Far less reported …
men (GBM) has explored facilitators and barriers to uptake and adherence. Far less reported …
Is insurance a barrier to HIV preexposure prophylaxis? Clarifying the issue
Clinical trials have demonstrated that preexposure prophylaxis (PrEP) protects against HIV
infection; yet, even with its approval by the Food and Drug Administration (FDA) in 2012 …
infection; yet, even with its approval by the Food and Drug Administration (FDA) in 2012 …
[HTML][HTML] Policy-and county-level associations with HIV pre-exposure prophylaxis use, the United States, 2018
Purpose HIV pre-exposure prophylaxis (PrEP) is highly efficacious, and yet most individuals
indicated for it are not currently using it. To provide guidance for health policymakers …
indicated for it are not currently using it. To provide guidance for health policymakers …
Addressing gaps in HIV preexposure prophylaxis care to reduce racial disparities in HIV incidence in the United States
SM Jenness, KM Maloney, DK Smith… - American journal of …, 2019 - academic.oup.com
The potential for human immunodeficiency virus (HIV) preexposure prophylaxis (PrEP) to
reduce the racial disparities in HIV incidence in the United States might be limited by racial …
reduce the racial disparities in HIV incidence in the United States might be limited by racial …
Considering stigma in the provision of HIV pre-exposure prophylaxis: Reflections from current prescribers
SK Calabrese, M Tekeste, KH Mayer… - AIDS patient care and …, 2019 - liebertpub.com
Efforts to identify and address social inequities in HIV pre-exposure prophylaxis (PrEP)
access are urgently needed. We investigated early-adopting PrEP prescribers' beliefs about …
access are urgently needed. We investigated early-adopting PrEP prescribers' beliefs about …
Interest in long-acting injectable pre-exposure prophylaxis (LAI PrEP) among women in the Women's Interagency HIV Study (WIHS): a qualitative study across six …
Long-acting injectable (LAI) pre-exposure prophylaxis (PrEP) has the potential to facilitate
adherence and transform HIV prevention. However, little LAI PrEP research has occurred …
adherence and transform HIV prevention. However, little LAI PrEP research has occurred …
Exploring preferences and decision-making about long-acting injectable HIV pre-exposure prophylaxis (PrEP) among young sexual minority men 17–24 years old
Intramuscular cabotegravir for long-acting injectable HIV pre-exposure prophylaxis (ie, LAI-
PrEP) was approved by the US FDA in 2021. We sought to explore LAI-PrEP decision …
PrEP) was approved by the US FDA in 2021. We sought to explore LAI-PrEP decision …
Pre-exposure prophylaxis (PrEP) for HIV infection in cisgender and transgender women in the US: a narrative review of the literature
A Baldwin, B Light, WE Allison - Archives of sexual behavior, 2021 - Springer
Using a socioecological approach, this review describes the peer-reviewed literature on oral
pre-exposure prophylaxis (PrEP) among both cisgender (cis women) and transgender …
pre-exposure prophylaxis (PrEP) among both cisgender (cis women) and transgender …